ART26.12, a novel fatty acid-binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models.

Autor: Warren WG; Artelo Biosciences Ltd., Alderley Park, Alderley Edge, Cheshire, UK., Osborn M; Artelo Biosciences Ltd., Alderley Park, Alderley Edge, Cheshire, UK., David-Pereira A; Transpharmation Ltd., The London Bioscience Innovation Centre, London, UK., Tsantoulas C; Transpharmation Ltd., The London Bioscience Innovation Centre, London, UK., Xue W; Pharmaron Inc., Beijing, People's Republic of China., Yates A; Artelo Biosciences Ltd., Alderley Park, Alderley Edge, Cheshire, UK., OSullivan SE; Artelo Biosciences Ltd., Alderley Park, Alderley Edge, Cheshire, UK.

Publikováno v: European journal of pain (London, England) [Eur J Pain] 2024 Aug 26. Date of Electronic Publication: 2024 Aug 26.